ABBV hasn’t disclosed any licensing agreements related to HCV other than the one with ENTA for ABT-450 and ABT-493. ABBV probably does have some small royalties payable to academic institutions for ABT-267 and ABT-333, but they don’t reach the threshold of materiality in SEC filings.
Market Data 
Markets 
AI
